University of delaware niimbl. Lee Kelvin H.
University of delaware niimbl. UD is innovating research, academics and workforce training in the cutting-edge field of biopharmaceuticals. 1. Opened in February 2020, the Ammon Pinizzotto Biopharmaceutical Innovation Center on the University of Delaware campus serves as NIIMBL headquarters. NIIMBL BIOLOGIC PRIMER The NIIMBL bioLOGIC Primer (PM. 1, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce student applications are now open for the 2026 Jun 5, 2024 · Planned to be next to the Ammon Pinizzotto Biopharmaceutical Innovation Center on the STAR Campus, the facility will be a 70,000 square-foot facility that will give NIIMBL the ability to “scale up. NIIMBL occupies two floors of the 200,000 square foot building with administrative offices, shared laboratory space, platform process facilities, a showcase laboratory, and workforce training areas. He received a BSE in Chemical Engineering from Princeton and PhD in NIIMBL helps advance biopharmaceutical manufacturing, solve industry challenges, and develop the skilled workforce of the future. Jan 9, 2023 · NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) received $15 million in total federal earmarks last month to support its planned expansion on the University of Delaware’s STAR Campus. Oct 1, 2025 · NIIMBL works to enhance innovative manufacturing capabilities and develop a world-leading manufacturing workforce for the biopharmaceutical industry. Jul 16, 2021 · NIIMBL, a public-private partnership founded in 2017 and headquartered at the University of Delaware’s Science, Technology and Advanced Research (STAR) Campus, has more than 180 members, representing large industries, small businesses, academic institutions, non-profit and federal agencies. mdcg yy ep2j yckkf u7wupt nah 9zr04b w1h 1x dpphg2
Back to Top
